The post Tom Lee targets $2,500 as the exhaustion point for Ethereum sellers appeared on BitcoinEthereumNews.com. Key Takeaways Tom Lee suggests Ethereum sellers may exhaust at the $2,500 level based on Tom DeMark’s analysis. Ethereum’s “minor” downside may precede a massive rally to $7,000–$9,000 by the end of January, according to Lee. Tom Lee sees a potential buy setup if Ethereum slides to $2,500. The founder of Fundstrat and chairman of BitMine Immersion, which now owns 3% of the total ETH supply, believes that level would represent a healthy market bottom, citing analysis from strategic advisor Tom DeMark. “In our conversations, when he looks at Ethereum, he (DeMark) sees what looks like engineered or systematic liquidation taking place,” Lee explained the recent market pullback during a recent interview with Chris Perkins, president of CoinFund. “There is someone that is capital constrained and is therefore bleeding or having to sell reflexively as price falls.” “That process is painful, but in his sort of rough timing range, his downside target, and we talked about this a few weeks ago, was $2,500 for ETH,” Lee added. “I think we’re so close to that. It would be ideal for us to actually bleed to that level, because then that is creating what he calls a buy setup.” Ethereum has declined from $4,800 to around $2,800, underperforming the S&P 500, which continued rising for 20 days after Ethereum’s peak. Lee attributed the divergence partly to the October 10 market crash in crypto that caused automatic deleveraging and caught market makers off guard. BitMine recently announced a staking network called MAVEN, which will launch with three to four unnamed partners to provide what Lee described as an “OFAC-friendly, US Treasury-friendly, Wall Street-friendly” solution. The firm also made a $20 million investment in Orbs, the token associated with WorldCoin, an ERC-20 project that provides proof of human verification through iris scanning. Lee said… The post Tom Lee targets $2,500 as the exhaustion point for Ethereum sellers appeared on BitcoinEthereumNews.com. Key Takeaways Tom Lee suggests Ethereum sellers may exhaust at the $2,500 level based on Tom DeMark’s analysis. Ethereum’s “minor” downside may precede a massive rally to $7,000–$9,000 by the end of January, according to Lee. Tom Lee sees a potential buy setup if Ethereum slides to $2,500. The founder of Fundstrat and chairman of BitMine Immersion, which now owns 3% of the total ETH supply, believes that level would represent a healthy market bottom, citing analysis from strategic advisor Tom DeMark. “In our conversations, when he looks at Ethereum, he (DeMark) sees what looks like engineered or systematic liquidation taking place,” Lee explained the recent market pullback during a recent interview with Chris Perkins, president of CoinFund. “There is someone that is capital constrained and is therefore bleeding or having to sell reflexively as price falls.” “That process is painful, but in his sort of rough timing range, his downside target, and we talked about this a few weeks ago, was $2,500 for ETH,” Lee added. “I think we’re so close to that. It would be ideal for us to actually bleed to that level, because then that is creating what he calls a buy setup.” Ethereum has declined from $4,800 to around $2,800, underperforming the S&P 500, which continued rising for 20 days after Ethereum’s peak. Lee attributed the divergence partly to the October 10 market crash in crypto that caused automatic deleveraging and caught market makers off guard. BitMine recently announced a staking network called MAVEN, which will launch with three to four unnamed partners to provide what Lee described as an “OFAC-friendly, US Treasury-friendly, Wall Street-friendly” solution. The firm also made a $20 million investment in Orbs, the token associated with WorldCoin, an ERC-20 project that provides proof of human verification through iris scanning. Lee said…

Tom Lee targets $2,500 as the exhaustion point for Ethereum sellers

2025/11/27 02:10
2 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

Key Takeaways

  • Tom Lee suggests Ethereum sellers may exhaust at the $2,500 level based on Tom DeMark’s analysis.
  • Ethereum’s “minor” downside may precede a massive rally to $7,000–$9,000 by the end of January, according to Lee.

Tom Lee sees a potential buy setup if Ethereum slides to $2,500. The founder of Fundstrat and chairman of BitMine Immersion, which now owns 3% of the total ETH supply, believes that level would represent a healthy market bottom, citing analysis from strategic advisor Tom DeMark.

Ethereum has declined from $4,800 to around $2,800, underperforming the S&P 500, which continued rising for 20 days after Ethereum’s peak. Lee attributed the divergence partly to the October 10 market crash in crypto that caused automatic deleveraging and caught market makers off guard.

BitMine recently announced a staking network called MAVEN, which will launch with three to four unnamed partners to provide what Lee described as an “OFAC-friendly, US Treasury-friendly, Wall Street-friendly” solution.

The firm also made a $20 million investment in Orbs, the token associated with WorldCoin, an ERC-20 project that provides proof of human verification through iris scanning. Lee said WorldCoin offers a “cryptographic hash of your iris” without storing biometric information.

Bitmine announced an annual dividend of one cent per share, representing less than 1% of expected earnings.

The stock trades at approximately $1.6 billion per day, making it the 50th most traded stock in the US.

Lee maintains his long-term view that Ethereum will enter what he calls a supercycle, driven by the tokenization of traditional assets.

Source: https://cryptobriefing.com/ethereum-exhaustion-point-tom-lee/

Opportunità di mercato
Logo TOMCoin
Valore TOMCoin (TOM)
$0.0000675
$0.0000675$0.0000675
-0.69%
USD
Grafico dei prezzi in tempo reale di TOMCoin (TOM)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Condividi
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Condividi
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Condividi
BitcoinEthereumNews2025/09/18 03:11